NextPoint Therapeutics is a clinical-stage biotechnology company based at 238 Main Street in Cambridge, Massachusetts, developing precision immuno-oncology therapeutics built on its scientific work on the novel B7-H7/HHLA2 checkpoint axis. Its pipeline includes a T-cell engager engineered for an improved therapeutic index, an antibody-drug conjugate using proprietary linker technology, and a multi-functional checkpoint inhibitor, each aimed at tumors that upregulate B7-H7. The company publishes a seven-page corporate marketing site covering its science, pipeline, leadership, and news; it operates no developer program, publishes no API, SDK, or machine-readable specification, and is profiled here for network completeness rather than for an API surface.
NextPoint Therapeutics is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Pharmaceuticals, Oncology, and Immunotherapy.
NextPoint Therapeutics’ developer surface includes product news and 7 more developer resources.
Regulatory Posture applies to this provider. Its tags matched the
Health regime, so
Regulatory Posture carries 15 points of the composite.
If this regime is wrong for your business, say so on your
provider repo — the
applicability map is public and we will correct it.
The six quality facets above are damped to 85 points between them,
because the conditional facet above carries the other
15. That is why each facet's contribution is shown against a damped
maximum: raising a quality facet moves the composite by 85% of its nominal
weight, not 100%. The full arithmetic is at apis.io/rating/.
aid: nextpoint-therapeutics
name: NextPoint Therapeutics
description: NextPoint Therapeutics is a clinical-stage biotechnology company based at 238 Main Street in Cambridge, Massachusetts,
developing precision immuno-oncology therapeutics built on its scientific work on the novel B7-H7/HHLA2 checkpoint axis.
Its pipeline includes a T-cell engager engineered for an improved therapeutic index, an antibody-drug conjugate using proprietary
linker technology, and a multi-functional checkpoint inhibitor, each aimed at tumors that upregulate B7-H7. The company
publishes a seven-page corporate marketing site covering its science, pipeline, leadership, and news; it operates no developer
program, publishes no API, SDK, or machine-readable specification, and is profiled here for network completeness rather
than for an API surface.
url: https://raw.githubusercontent.com/api-evangelist/nextpoint-therapeutics/refs/heads/main/apis.yml
deliveryModel:
model: saas
open_source: false
commercial: true
callable_host: false
label: Hosted service · you call their endpoint
confidence: medium
source:
- pricing
generated: '2026-08-28'
method: derived
accessModel:
pricing: unknown
onboarding: unknown
trial: false
try_now: false
public: false
label: Unknown
confidence: low
source:
- security
generated: '2026-09-02'
method: derived
image: https://nextpointtx.com/wp-content/uploads/2025/08/logo-nextpoint.png
x-type: company
x-source: harvest:secondary-market
x-tier: stub
x-tier-reason: harvest
specificationVersion: '0.20'
created: '2026-08-26'
modified: '2026-08-26'
tags:
- Company
- Biotechnology
- Pharmaceuticals
- Oncology
- Immunotherapy
- Life Sciences
- Healthcare
- Clinical Trials
apis: []
maintainers:
- FN: Kin Lane
email: kin@apievangelist.com
- FN: APIs.json
email: info@apis.io
common:
- type: DomainSecurity
url: security/nextpoint-therapeutics-domain-security.yml
- type: Website
url: https://nextpointtx.com/
- type: PrivacyPolicy
url: https://nextpointtx.com/privacy-policy/
- type: TermsOfService
url: https://nextpointtx.com/terms-of-use/
- type: News
url: https://nextpointtx.com/news-publications/
- type: LinkedIn
url: https://www.linkedin.com/company/nextpoint-therapeutics/
- type: Twitter
url: https://x.com/NextPointTX
- type: SecondaryMarketListing
url: https://forgeglobal.com/nextpoint-therapeutics_stock/
x-enrichment:
date: '2026-08-26'
status: minimal
artifacts_added: 2
pass: local-v1
x-coverage:
state: none
reason: not-a-software-company
detail: NextPoint Therapeutics is a clinical-stage drug developer whose entire web presence is a seven-page WordPress marketing
site with no developer program — every /openapi.json, /swagger.json, /graphql, /api-docs and /.well-known/* path returns
the byte-identical 158,191-byte catch-all homepage rather than a document, and the only machine-readable surface on the
host is the default WordPress /wp-json/ CMS route index, which is WordPress plumbing and not a NextPoint API product.
evidence:
- url: https://nextpointtx.com/openapi.json
status: 200
- url: https://nextpointtx.com/definitely-not-a-real-path-abc123
status: 200
- url: https://nextpointtx.com/.well-known/security.txt
status: 404
- url: https://nextpointtx.com/llms.txt
status: 404
- url: https://api.github.com/orgs/nextpointtx
status: 404
checked: '2026-08-26'